Breaking News
Sort by:
Top Post
Experimental Cancer Drug May Slow Inflammation Linked to Heart Disease
An experimental drug already tested as a potential treatment for cancer, lung, and Alzheimer’s disease […]
Medtronic Hugo™ Robotic-Assisted Surgery System Receives European CE Mark Approval
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced it has received CE (Conformité […]
First Procedure in Asia-Pacific Performed with Medtronic Hugo ™ Robotic-Assisted Surgery System
Medtronic plc (NYSE:MDT) and Apollo Hospitals Group today announced the first clinical procedure in Asia-Pacific with […]
First Gynecological Procedures Performed with Medtronic Hugo ™ Robotic-Assisted Surgery System
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first gynecological (GYN) […]
First Procedure in the World with Medtronic Hugo™ Robotic-Assisted Surgery System Performed at Clínica Santa Maria in Chile
Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced the first patient procedure […]
- Eloxx Pharmaceuticals Announces Final Data Assessment from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis Patients Read more
- Verge Genomics Announces Positive Safety and Tolerability Data from the Phase 1 Clinical Trial of VRG50635, a Potential Best-in-Class Therapeutic for All Forms of ALS Read more
- DEM BioPharma Appoints Wendy Young, Ph.D., to Scientific Advisory Board Read more
- Confo Therapeutics Enters into Research Collaboration for GPCR-Targeting Antibody Discovery with AbCellera Read more
- Vyriad Announces Expansion of T-Cell Lymphoma Trial at Mayo Clinic Read more